Hip fracture discrimination from dual-energy X-ray absorptiometry by statistical model registration.

Although the areal Bone Mineral Density (BMD) measurements from dual-energy X-ray absorptiometry (DXA) are able to discriminate between hip fracture cases and controls, the femoral strength is largely determined by the 3D bone structure. In a previous work a statistical model was presented which parameterizes the 3D shape and BMD distribution of the proximal femur. In this study the parameter values resulting from the registration of the model onto DXA images are evaluated for their hip fracture discrimination ability with respect to regular DXA derived areal BMD measurements. The statistical model was constructed from a large database of QCT scans of females with an average age of 67.8 ± 17.0 years. This model was subsequently registered onto the DXA images of a fracture and control group. The fracture group consisted of 175 female patients with an average age of 66.4 ± 9.9 years who suffered a fracture on the contra lateral femur. The control group consisted of 175 female subjects with an average age of 65.3 ± 10.0 years and no fracture history. The discrimination ability of the resulting model parameter values, as well as the areal BMD measurements extracted from the DXA images were evaluated using a logistic regression analysis. The area under the receiver operating curve (AUC) of the combined model parameters and areal BMD values was 0.840 (95% CI 0.799-0.881), whilst using only the areal BMD values resulted in an AUC of 0.802 (95% CI 0.757-0.848). These results indicate that the discrimination ability of the areal BMD values is improved by supplementing them with the model parameter values, which give a more complete representation of the subject specific shape and internal bone distribution. Thus, the presented method potentially allows for an improved hip fracture risk estimation whilst maintaining DXA as the current standard modality.

Blackcurrant seed press residue increases tocopherol concentrations in serum and stool whilst biomarkers in stool and urine indicate increased oxidative stress in human subjects.

Berry seeds are a tocopherol-rich by-product of fruit processing without specific commercial value. In a human intervention study, the physiological impact of blackcurrant seed press residue (PR) was tested. Thirty-six women (aged 24 +/- 3 years; twenty non-smokers, sixteen smokers) consumed 250 g bread/d containing 8% PR for a period of 4 weeks (period 3). Comparatively, a control bread without PR (250 g/d) was tested (period 2) and baseline data were obtained (period 1). Blood, stool and 24 h urine were collected during a 5 d standardised diet within each period. Tocopherol and Fe intakes were calculated from food intake. In serum, tocopherol concentration and Fe parameters were determined. In urine, oxidative stress markers 8-oxo-2'-deoxyguanosine, 8-iso-PGF2alpha and inflammatory response marker 15-keto-dihydro-PGF2alpha were analysed. Stool tocopherol concentration, genotoxicity of faecal water (comet assay) and antioxidant capacity of stool (aromatic hydroxylation of salicylic acid) were determined. Fe and total tocopherol intake, total tocopherol concentrations in serum and stool, and genotoxicity of faecal water increased with PR bread consumption (P < 0.05). The antioxidant capacity of stool decreased between baseline and intervention, expressed by increased formation of 2,3- and 2,5-dihydroxybenzoic acid in vitro (P < 0.05). In smokers, 8-oxo-2'-deoxyguanosine increased with PR consumption (P < 0.05). Prostane concentrations were unaffected by PR bread consumption. In summary, the intake of bread containing blackcurrant PR for 4 weeks increased serum and stool total tocopherol concentrations. However, various biomarkers indicated increased oxidative stress, suggesting that consumption of ground berry seed may not be of advantage.

Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis.

n-3 long-chain PUFA (n-3 LC-PUFA) may improve cardiovascular and inflammatory diseases. The effects of n-3 LC-PUFA-supplemented dairy products on inflammation and immunological parameters, biomarkers of oxidative stress, serum lipids, and on disease activity were determined in patients with rheumatoid arthritis (RA). Forty-five subjects (forty-three females and two males) were randomly divided into two groups in a double-blind, placebo-controlled cross-over study. Both groups received placebo or verum products consecutively for 3 months with a 2-month washout phase between the two periods. Blood samples were taken at the beginning and at the end of each period. The dairy products generally improved serum lipids by increasing HDL and lowering lipoprotein a. The n-3 LC-PUFA supplements act to lower TAG. Additionally, a decreased lipopolysaccharide-stimulated cylo-oxygenase-2 expression was found in patients who had consumed the enriched dairy products. The majority of the CD analysed were not influenced, although n-3 LC-PUFA did suppress the immune response as lymphocytes and monocytes were found to be significantly decreased. The n-3 LC-PUFA did not increase the biomarkers of oxidative stress such as 8-iso-PGF(2alpha) and 15-keto-dihydro PGF(2alpha), and DNA damage like 7,8-dihydro-8-oxo-2'-deoxyguanosine. The long-term consumption of dairy products (2 x 12 weeks) diminished the excretion of hydroxypyridinium crosslinks, and favoured the diastolic blood pressure. The consumption of moderate doses of n-3 LC-PUFA in combination with dairy products did not improve the disease activity. However, there is evidence of cardioprotective effects. Furthermore, the long-term consumption of dairy products acts against the cartilage and bone destruction in RA.